NanoVax-Panflu

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameNanoVax-Panflu

Drug Alias NameNE-rH5 influenza vaccine (BlueWillow)recombinant H5N1 pandemic influenza antigen vaccine (BlueWillow)recombinant H5N1 pandemic influenza antigen vaccine (NanoBio)NE-rH5 influenza vaccine (NanoBio)

ClassificationVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBluewillow Biologics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBluewillow Biologics Inc

Active IndicationsN/A

Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A